Pituitary adenylate cyclase-activating polypeptide ameliorates vascular dysfunction induced by hyperglycaemia
BACKGROUND: Short-lasting hyperglycaemia occurs frequently in prediabetes and poorly controlled diabetes mellitus leading to vascular damage. Pituitary adenylate cyclase-activating polypeptide (PACAP) has been shown to play a protective role in vascular complications of diabetes; moreover, antioxida...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2018
|
| Sorozat: | DIABETES & VASCULAR DISEASE RESEARCH
15 No. 4 |
| doi: | 10.1177/1479164118757922 |
| mtmt: | 3339992 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/13673 |